220
M. Catasu´s et al. / Journal of Organometallic Chemistry 642 (2002) 212–226
In a similar way, 0.273 g (0.71 mmol) of (2R,3R)-
133.0 (CH), 134.7*, 135.5 (CH), 155.8 (Cq, CO) (*
signal corresponding to a rotamer of the N-Boc group).
MS (CI, NH3) m/e=497 [M−NHBoc+, 32%], 556
[M−tBu+, 100%], 613 [M+, 55%], 614 [M+1+, 47%],
393 [M+18+, 6%]. HRMS (EI) Calc. for
C34H43FeNO4Si: 613.2311. Found: 613.2299.
azido acetate ((−)-6), treated with 0.188 g (4.96 mmol)
of LiAlH4 in 7 ml THF, gave 0.124 g (64%) of
(2R,3R)-3-amino-3-ferrocenylpropane-1,2-diol ((−)-7).
3.1.7. (2S,3S)-3-(tert-Butoxycarbonylamino)-3-
ferrocenylpropane-1,2-diol ((+)-8)
A mixture of 3-amino-3-ferrocenyilpropane-1,2-diol
((+)-7) (69 mg, 0.25 mmol), di-tert-butyl dicarbonate
(66 mg, 0.30 mmol) and NaHCO3 (63 mg, 0.75 mmol)
in MeOH (1.3 ml) was sonicated in a cleaning bath at
r.t. for 2 h. The solids were filtered off and washed with
MeOH. Concentration of the filtrate and column chro-
matography on Et3N-pretreated silica gel (2.5% v/v),
eluting with C6H14–EtOAc mixtures of increasing po-
larity, gave 73 mg (78%) of the N-Boc amino alcohol
(+)-8 as an orange-coloured semi-solid.
3.1.9. (4S,5S)-N-(tert-Butoxycarbonyl)-2,2-
dimethyl-4-ferrocenyl-5-[(tert-butyldiphenylsilyloxy)-
methyl]-1,3-oxazolidine (10)
A solution of (+)-9 (30 mg, 0.05 mmol) and 2,2-
dimethoxypropane (65 ml, 0.50 mmol) in C6H6 (0.2 ml)
was heated to reflux for 5.5 h in the presence of a trace
of p-toluenesulfonic acid, diluted with EtOAc (10 ml)
and washed with aq. sat. NaHCO3 and with brine.
After drying over Na2SO4, elimination of the solvents
followed by chromatographic purification on Et3N-pre-
treated silica gel using C6H14–EtOAc mixtures of in-
creasing polarity as eluents afforded 22 mg (69%) of the
oxazolidine 10 as an orange–yellow oil.
[h]D= +17.9° (c=1.75, CHCl3). IR (NaCl film):
w=3406, 3097, 2979, 1686, 1507, 1368, 1250, 1169,
1
1050 cm−1. H-NMR (200 MHz, CDCl3): l (ppm) 1.26
(t, J=4 Hz, 1H, OH), 1.50 (s, 9H), 2.85 (br, 1H, OH),
3.52 (m, 2H), 3.79 (m, 1H), 4.20 (m, 9H), 4.61 (dd,
J=8.8 Hz, J%=2.6 Hz, 1H), 5.19 (br d, J=8.8 Hz,
1H, NH). 13C-NMR (50 MHz, CDCl3): l (ppm) 28.4
(CH3), 51.0 (CH), 63.3 (CH2), 65.8 (CH), 67.8 (CH),
68.0 (CH), 68.8 (CH), 74.9 (CH), 80.3 (Cq), 87.8 (Cq,
Cp), 157.1 (Cq, CO). MS (CI, NH3) m/e=259 [M−
NHBoc+, 16%], 375 [M+, 51%], 376 [M+1+, 11%],
393 [M+18+, 2%]. HRMS (EI) Calc. for
C18H25FeNO4: 375.1133. Found: 375.1132.
IR (NaCl film): w=3074, 2933, 2860, 1700, 1378,
1108 cm−1 1H-NMR (300 MHz, 55 °C, CDCl3): l
.
(ppm)=1.10 (m, 12H), 1.46 (m, 9H), 3.77 (d, J=6.3
Hz, 2H), 4.13 (m, 9H), 4.69 (m, 1H, CH), 4.93 (m, 1H,
CH), 7.41 (m, 6H), 7.72 (m, 4H). 13C-NMR (75 MHz,
55 °C, CDCl3): l (ppm) 19.3 (Cq), 26.7 (CH3), 27.0
(CH3), 28.6 (CH3), 58.1 (CH), 65.8 (CH2), 66.7 (CH),
67.6 (CH), 68.6 (CH), 79.8 (Cq, Cp), 127.7 (CH), 129.6
(CH), 129.8 (CH), 133.3 (CH), 133.4 (CH), 133.4 (CH),
134.9 (CH), 135.7 (CH), 151.8 (Cq, CO). MS (CI, NH3)
m/e=654 [M+1+, 57%], 671 [M+18+, 4%]. HRMS
(EI) Calc. for C37H47FeNO4Si: 653.2624. Found:
653.2638.
3.1.8. (2S,3S)-1-(tert-Butyldiphenylsilyloxy)-3-
(tert-butoxycarbonylamino)-3-ferrocenyl-2-propanol
((+)-9)
A mixture of the N-Boc amino alcohol (+)-8 (0.100
g, 0.27 mmol), DMF (1.3 ml), imidazole (41 mg, 0.59
mmol) and tert-butyldiphenilsilylchloride (0.78 ml, 0.30
mmol) was stirred at r.t. for 24 h, diluted with Et2O (5
ml) and washed with aq. sat. NH4Cl solution (3×5
ml). The aq. phase was washed with Et2O (3×5 ml),
and the combined organic phase was dried over
Na2SO4. Elimination of the solvents, followed by chro-
matographic purification on Et3N-pretreated silica gel
using C6H14–EtOAc mixtures of increasing polarity as
eluents afforded 0.145 g (89%) of the title compound as
an orange–yellow semi-solid.
3.1.10. (4S,5S)-4-Ferrocenyl-5-(hidroxymethyl)-1,3-
oxazolidin-2-one ((+)-11)
To an stirred suspension of NaH (60% in paraffine
oil, 12 mg, 0.30 mmol) in DMF (1 ml), a solution of
(+)-9 (73 mg, 0.12 mmol) in DMF (0.76 ml) was
added via cannula. The resulting mixture was stirred at
r.t. for 1.5 h, treated with aq. 1 M HCl (1.5 ml) and
extracted with CH2Cl2 (3×5 ml). The organic extracts
were washed with brine, dried over Na2SO4 and submit-
ted to rotative evaporation to give a crude product that
after chromatographic purification (Et3N-pretreated sil-
ica gel, C6H14–EtOAc mixtures) afforded 30 mg (83%)
of the oxazolidinone (+)-11 as a yellow solid.
M.p. 178 °C (dec.). [h]D= +41.8° (c=0.45,
C2H4O). IR (KBr): w=3365, 2925, 1729, 1414, 1364,
1106, 1052, 1027 cm−1. 1H-NMR (200 MHz, CDCl3): l
(ppm) 3.68 (br s, 1H, OH), 3.75 (m, 1H), 3.90 (m, 1H),
4.20 (m, 9H), 4.38 (m, 1H), 4.60 (d, J=6.4 Hz, 1H),
5.26 (br s, 1H, NH). 13C-NMR (75 MHz, Me2SO-d6): l
(ppm) 52.5 (CH), 62.1 (CH2), 65.9 (CH), 66.3 (CH),
68.1 (CH), 68.4 (CH), 68.8 (CH), 82.9 (CH), 90.0 (Cq,
Cp), 158.5 (Cq, CO). MS (CI, NH3) m/e=302 [M+1+,
[h]D= +8.3° (c=1.10, CHCl3). IR (NaCl film): w=
3438, 3074, 2933, 1694, 1505, 1428, 1169, 1113 cm−1
.
1H-NMR (200 MHz, CDCl3): l (ppm) 1.08 (s, 9H),
1.43 (s, 9H), 2.66 (br s, 1H, OH), 3.61 (m, 2H), 3.93 (m,
1H), 4.11 (m, 9H), 4.55 (br d, J=7.8 Hz, 1H), 5.21 (br
d, J=8.0 Hz, 1H, NH), 7.41 (m, 6H), 7.64 (m, 4H).
13C-NMR (50 MHz, CDCl3): l (ppm) 19.3 (Cq), 26.6
(CH3), 26.9 (CH3), 28.4 (CH3), 50.5 (CH), 65.3 (CH2),
66.6 (CH), 67.3 (CH), 67.7 (CH), 68.7 (CH), 74.5 (CH),
89.1 (Cq, Cp), 127.6*, 127.7 (CH), 129.6*, 129.8 (CH),